ECG and Cardiac enzyme changes in patients with Stroke
Not Applicable
- Conditions
- Health Condition 1: I63- Cerebral infarction
- Registration Number
- CTRI/2022/10/046255
- Lead Sponsor
- Antony Jose
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Adult patients admitted within 24 hours of onset of symptoms of acute ischemic stroke.
Exclusion Criteria
Hemorrhagic stroke.
Cardioembolic stroke ââ?¬â?? as evidenced by prior history of valvular or ischemic heart disease, or cardia arrhythmias,cardiac surgery.
Echocardiogram at admission revealing valvular heart disease, atrial thrombus, regional wall motion abnormality or ejection fraction less than 50%
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Monitoring of cardiac enzymes would guide prevention and treatment of cardiac disease in patients with stroke. Patients with greater biomarker elevation may be considered for early coronary evaluation and interventionTimepoint: 1 year
- Secondary Outcome Measures
Name Time Method Elevated biomarkers would help in stroke prognostication.Timepoint: 1 year